Company
BrightGene Bio-Medical Technology Co., Ltd.
BrightGene Bio-Medical Technology Co., Ltd. has 2 drugs tracked on RxWires: 1 in Phase 3, 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Drug: : 10 mg BGM0504 Administered SC | Phase 3 | Type 2 Diabetes Mellitus (T2DM) |
| BGM1812 | Phase 1 | Healhty |
Latest
No recent events.
Follow BrightGene Bio-Medical Technology Co., Ltd. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.